Search
Displaying all 3 results
Afamitresgene autoleucel
go.drugbank.com/drugs/DB18592
ApprovedInvestigational
Afamitresgene autoleucel is a melanoma-associated antigen A4 (MAGE-A4)-directed genetically modified autologous T cell immunotherapy product consisting of CD4 and CD8 positive T cells transduced with a self-inactivating lentiviral vector (LV) expressing an affinity-enhanced T cell receptor (TCR) specific for the hum...
Unresectable Synovial Sarcoma
go.drugbank.com/conditions/DBCOND0115032Drugs: Afamitresgene autoleucel